Table 1.
CTL | PNE | |||||
---|---|---|---|---|---|---|
Mean | SE | Range | Mean | SE | Range | |
Gestational age at birth (days)a | 279.9 | 1.9 | 266–294 | 270.4 | 1.4 | 261–278 |
Postmenstrual age at EEGb | 418.4 | 3.3 | 400–446 | 419.4 | 5.6 | 381–455 |
Age at EEG, months | 4.61 | 0.5 | 4.0–5.5 | 4.96 | 0.8 | 3.9–6.2 |
Birth weight, gramsc | 3610.5 | 118 | 2778–4423 | 3130.6 | 156 | 2155–4111 |
Male, n (%) | 7 (.44) | 7 (.47) | ||||
Nonwhite | 4 (.25) | 4 (.24) | ||||
3rd Trimester Maternal expired CO, ppmd | 1.67 | 0.14 | 1.0–2.0 | 9.6 | 2.5 | 1.0–33.5 |
3rd Trimester Maternal COHb, %d | 1.00 | 0.08 | 0.8–1.8 | 2.2 | 0.4 | 0.8–6.0 |
Cigarettes/day Trimester 1e | 0 | 14.1 | 1.9 | 5–20 | ||
Cigarettes/day Trimester 2e | 0 | 7.7 | 2.0 | 0–20 | ||
Cigarettes/day Trimester 3e | 0 | 5.5 | 1.4 | 0–10 | ||
Maternal Cotinine 3rd Trimesterf,g | 1.97 | 0.44 | 0.3–5.3 | 104.5 | 29.8 | 31–520 |
Maternal Postpartum expired CO, ppma | 2.27 | 1.15 | 1.0–7.0 | 9.7 | 1.4 | 1.0–26.0 |
K-Complex Characteristics | ||||||
% of acceptable ERP epochsg | 28.1 | 2.3 | 9.5–41 | 25.3 | 2.3 | 15–42 |
Peak-to-peak amplitudeh, µVg | 122.04 | 11.9 | 55.8–216.2 | 102.0 | 6.8 | 65.6–161.2 |
Delta power of N550, µV^2g | 1574.3 | 343 | 231–5496 | 907.4 | 89.6 | 479–1789.5 |
Abbreviations: CTL, drug free control, n = 17; PNE, prenatal nicotine exposure n = 16; SE, standard error of the mean; CO, carbon monoxide; PPM, parts per million; Hb, hemoglobin
a p < .001.
bdays since conception;
c p <.09,
d p < .01, Gestational age at birth, birthweight, Maternal COHb, CO, and cotinine results of 2-sample t-test, df: 2, 31.
eTime Line Follow Back Interview.
f Maternal urinary cotinine (ng cotinine per mg creatinine).
g[AQ: Please provide significance for “g.”]
hPeak-to-peak difference between P200 and N550 components of elicited K-complex, adjusted for gestational age at EEG.